The Middle EAST Speech Biomarkers Market was valued at USD 0.45 billion in 2024 and is projected to reach USD 1.20 billion by 2034, registering a CAGR of 10.0%. This growth trajectory is underpinned by the increasing demand for advanced diagnostic tools in healthcare, particularly in the fields of neurology and mental health. The rising prevalence of neurological disorders, coupled with the...